Thiagarajan P, Kelly K
Department of Medicine, University of Washington, Seattle.
Thromb Haemost. 1988 Dec 22;60(3):514-7.
Platelets adhere to vitronectin substrate following activation with physiological concentrations of thrombin. Adhesion of activated platelets to vitronectin substrate is dependent upon the presence of divalent cations, the amount of vitronectin, and the duration of adhesion assay. The adhesion of platelets is inhibited by synthetic peptides containing the sequence of Arg-Gly-Asp. In addition, monoclonal antibodies to glycoprotein IIb-IIIa complex inhibit the adhesion of activated platelets to vitronectin substrate in a dose-dependent manner. These studies suggest that the glycoprotein IIb-IIIa complex on activated platelets may interact with vitronectin substrate through the Arg-Gly-Asp mechanism. Since vitronectin is present in the subendothelial matrix, it might be involved in platelet-vessel wall interactions.
血小板在用生理浓度的凝血酶激活后会黏附于玻连蛋白底物。活化血小板对玻连蛋白底物的黏附取决于二价阳离子的存在、玻连蛋白的量以及黏附测定的持续时间。血小板的黏附受到含有精氨酸 - 甘氨酸 - 天冬氨酸序列的合成肽的抑制。此外,针对糖蛋白IIb - IIIa复合物的单克隆抗体以剂量依赖的方式抑制活化血小板对玻连蛋白底物的黏附。这些研究表明,活化血小板上的糖蛋白IIb - IIIa复合物可能通过精氨酸 - 甘氨酸 - 天冬氨酸机制与玻连蛋白底物相互作用。由于玻连蛋白存在于内皮下基质中,它可能参与血小板与血管壁的相互作用。